MAMikhail Atyukov

Mikhail Atyukov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mikhail Atyukov has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prognostic value of surgical risk assessment scales in patients with centrally located malignant lung tumors

    by I.YU. Zemtsova, M.A. Atyukov, V.G. Pishchik, P.P. Yablonsky, P.K. Yablonsky

    Objective. To evaluate predictive value of current operative risk scales in non-small cell lung cancer (NSCLC) depending on tumor localization and identify independent predictors of 30-day mortality. Material and methods. A retrospective single-center cohort study enrolled 511 NSCLC patients who underwent anatomical lung resection (central tumors n=148, peripheral tumors n=363). Eurolung I/II, Modified Eurolung II, Thoracoscore, SABCIP, and ESOS scales were assessed by ROC analysis using a single Youden-derived cut-off applied uniformly across subgroups. Complications were classified as minor (Clavien-Dindo I–IIIa) or major (IIIb–V). Risk factors were identified by logistic regression. Results. Thirty-day mortality was 2.3% (12/511). In centrally located tumors, AUC fell to 0.581–0.729 versus 0.690–0.918 in peripheral tumors. Specificity dropped to 38–62%. Central localization showed a stepwise increase in prognostic impact: non-significant for minor complications (OR=1.249; p=0.289), significant for major complications (OR=2.604; 95% CI 1.209–5.609; p=0.014), and the strongest for mortality (OR=5.129; 95% CI 1.520–17.302; p=0.008). Multivariable analysis identified central localization (OR=3.593; p=0.046) and FEV1 <65% (OR=7.286; p=0.001) as independent predictors of mortality. The model delineates four risk groups with mortality from 0.71% to 15.8%. Conclusion. Current risk scales systematically underperform in central lung tumors. A two-factor model based on localization and FEV1 provides preoperative risk stratification and requires external validation.

  • Open Access

    Application of the EuroLung1 Risk Stratification Score and Its Modification in Patients with Stage I-IIA NSCLC

    by A. S. Petrov, D. A. Galitsky, M. A. Atyukov, O. A. Zhemchugova-Zelenova, I. Yu. Zemtsova, P. K. Yablonskiy, А. С. Петров, Д. А. Галицкий, М. А. Атюков, О. А. Жемчугова-Зеленова, et al.

    Objective : To evaluate the applicability of the EuroLung1 risk stratification model and its modification in a population of patients undergoing anatomical lung resections for stage I–IIA non-small cell lung cancer (NSCLC), performed predominantly via videoassisted thoracoscopic surgery (VATS). Materials and methods : A retrospective analysis of clinical data of 290 patients who underwent anatomical lung resections for stage I–IIA NSCLC was performed. The predicted risk of postoperative complications according to the EuroLung1 score was compared with the actual incidence of postoperative complications in the study cohort. Additionally, a modified scoring system was developed, which was used to evaluate the incidence of postoperative complications, including prolonged air leak through the pleural drainage system, cardiac arrhythmias, grade 1–3 respiratory failure, and complications of grade IIIA and higher according to the Clavien– Dindo classification. Results : Comparison of the predicted risk of complications according to the EuroLung1 score with the actual incidence of postoperative complications revealed no correlation (p=0.303). Statistically significant associations were observed when assessing the risk using proposed modification of the EuroLung1 model: prolonged air leak through the pleural drainage system (p=0.017), cardiac arrhythmias (p=0.016), grade 1–3 respiratory failure (p=0.009), complications classified as grade IIIA or higher according to the Clavien–Dindo classification (p=0.027), and overall postoperative complications (p=0.008). Conclusion: The EuroLung1 score demonstrates insufficient accuracy in predicting postoperative complications in patients undergoing surgery for stage I-IIA NSCLC stage; however, we have proposed an alternative approach to the application of this model, which demonstrated satisfactory predictive performance.

  • The Ludwig classification for assessment of bronchial anastomosis healing after sleeve lobectomies in central lung cancer patients

    by O.A. Zhemchugova-Zelenova, A.S. Petrov, V.E. Perederiy, M.A. Atyukov, S.A. Mishcheryakov, M.S. Martynikhina, V.G. Pishchik, P.K. Yablonskii

    Objective. To identify the correlation between Ludwig grades of bronchial anastomosis and bronchial complications after sleeve lobectomy in central non-small cell lung cancer patients, as well as to study perioperative factors influencing bronchial anastomosis healing. Material and methods. A retrospective study included 31 patients with central non-small cell lung cancer grade I-IIIA after sleeve lobectomy. They underwent fibrobronchoscopy in 7 days and 3-6 months after surgery. Results. Patients with good anastomotic healing after 7 postoperative days (Ludwig I-II) did not have bronchial complications in 65% of cases after 6 months; 35% of these patients had mild stenosis of anastomosis (grade I-II). Among patients with Ludwig grade III-V after 7 postoperative days, we found stenosis grade I-II in 20% of cases and grade III-IV in 40% of cases. Other 40% of patients in this group had bronchopleural fistula. Unfavorable prognostic factors of poor anastomotic healing (Ludwig grade ≥ III) were difference in diameter of sutured bronchi > 37.02% (p=0.046), VAMLA 6-10 days before sleeve lobectomy (p=0.033), and no covering of bronchial anastomosis (p=0.042). Conclusions. The Ludwig classification of bronchial anastomosis healing on postoperative day 7 is a significant tool to predict complications after sleeve lobectomy.

  • Surgical access and other prognostic factors influencing early and long-term outcomes after sleeve lobectomy in patients with centrally located lung cancer

    by O.A. Zhemchugova-Zelenova, M.A. Atyukov, A.S. Petrov, I.YU. Zemtsova, V.E. Perederii, E.I. Zinchenko, V.G. Pischik, P.K. Yablonskiy

    Objective. To improve the treatment outcomes of patients with central lung cancer by optimizing surgical approach. Material and methods. This retrospective multicenter study included 63 patients with I—III stage of central NSCLC who underwent sleeve lobectomy from May 2014 to April 2024 at three thoracic surgery centers in St. Petersburg. Results. The frequency of postoperative complications in I—II stage of central non-small cell lung cancer was 33.3% in the group of videothoracoscopic sleeve resections versus 61.1% in thoracotomy group (p=0.018). The overall 5-year survival rate was 61% in the thoracotomy group versus 90% in the videothoracoscopy group(p=0.046). Risk factors for the development of postoperative complications after sleeve lobectomies included thoracotomy (p=0.003), high body mass index (p=0.043), advanced stage of the tumor (p=0.002), and lack of covering of the bronchial anastomosis with flap (p=0.032). Independent unfavorable prognostic factors of long-term survival in patients after sleeve lobectomy include high body mass index (p=0.003), smoking history (p=0.009), intraoperative blood transfusion (p=0.036), and conversion of thoracoscopic access to thoracotomy (p=0.007). Conclusion. Videothoracoscopic sleeve lobectomies are associated with less postoperative complications in patients with I—II stages of central NSCLC, which allows to reliably reduce the incidence of postoperative complications and ensure good long-term treatment results. Several risk factors of complicated postoperative period and poor long-term survival were identified by multivariate analyzis.

  • Open Access

    Risk factors for postoperative complications and-mortality in patients with central non-small cell lung cancer

    by M. Ai. Atyukov, I. Yu. Zemtsova, T. R. Goguadze, И. Ю. Земцова

    Objective – to identify risk factors for postoperative complications and 30-day mortality in patients with central non-small cell lung cancer undergoing anatomical lung resections. This retrospective single-center study included 146 patients with central non-small cell lung cancer selected from a cohort of 509 patients who underwent anatomical lung resections between 2014 and 2025. Tumors were classified as central when located in the main, intermediate, lobar, or segmental bronchi. Clinical and demographic characteristics, pulmonary function parameters, clinicopathological tu-mor features, intraoperative variables, and postoperative laboratory data were analyzed. Postoperative complications were classified according to the modified Clavien – Dindo classification. Univariate and multivariate logistic regression analyses were performed to identify risk factors. Postoperative complications occurred in 68 of 146 patients (47 %). Minor complications (Clavien – Dindo grades I–IIIa) were observed in 54 patients (37 %), while major complications (grades IIIb–V) occurred in 14 patients (10 %). The 30-day mortality rate was 6 % (eight cases). In univariate analysis, the risk of postoperative complications was associated with the Charlson Comorbidity Index (OR 1.17; 95 % CI 1.00–1.38; p = 0.047), complicated tumor course (OR 2.12; 95 % CI 1.08–4.17; p = 0.029), presence of pulmonary hemorrhage (OR 2.43; 95 % CI 1.06–5.56; p = 0.036), emphysematous changes in the lung parenchyma (OR 3.29; 95 % CI 1.63–6.65; p = 0.001), and postoperative decrease in total protein levels (OR 1.05; 95 % CI 1.00–1.10; p = 0.041). In multivariate analysis, emphysema was the only independent predictor of postoperative complications (OR 3.03; 95 % CI 1.43–6.44; p = 0.004). Increased 30-day mortality was associated with impaired pulmonary function (categorical FEV₁, vital capacity, and predicted postoperative FEV₁) and greater intraoperative blood loss. Patients with central non-small cell lung cancer represent a clinically more complex group characterized by technically demanding surgical procedures and a higher risk of adverse postoperative outcomes. Emphysematous changes in the lung parenchyma are the most significant independent predictor of postoperative complications. Reduced pulmonary function and increased intraoperative blood loss are associated with higher 30-day mortality. Comprehensive assessment of clinical, functional, and intraoperative parameters allows for more accurate risk stratification and optimization of perioperative management in this patient population.

  • VAMLA and Anatomical Lung Resection under Single Anesthesia for Resectable NSCLC: First 100 Operations

    by A.S. Petrov, O.A. Zhemchugova-Zelenova, E.E. Pavlova, A.A. Skorokhod, I.YU. Zemtsova, M.A. Аtyukov, P.K. Yablonskiy

    The extent of lymph node dissection is one of the most critical issues discussed in the context of surgical treatment for non-small cell lung cancer (NSCLC), as the appropriate scope of intervention on the regional lymphatic system determines the accuracy of the final tumor stage, the need for adjuvant therapy, and contributes to improved long-term outcomes in lung cancer treatment. The most accurate pathological N stage can be established through bilateral mediastinal lymphadenectomy, for which the minimally invasive technique of video-assisted mediastinal lymphadenectomy (VAMLA) can be used in modern thoracic surgery. Doing VAMLA and anatomical lung resection under a single anesthesia has been described in only a few publications. The aim of our observational study was to evaluate the efficacy and safety of such a simultaneous intervention. Based on a detailed analysis of intra- and postoperative parameters from 100 patients, we found that performing VAMLA together with anatomical lung resection achieves high accuracy in final N-staging by removing a large number of lymph node groups for histological examination. Moreover, this simultaneous approach is not associated with any worsening in the early postoperative period, and is consistent with published results of standard anatomical resections for NSCLC. Thus, simultaneous performance of VAMLA and anatomical lung resection appears to be a promising option for surgical intervention in resectable NSCLC, especially for left-sided tumors, and requires further investigation via comparative studies.

  • Open Access

    Optimized Method for Establishing Primary Human Mesothelial Cell Cultures Preserving Epithelial Phenotype

    by Evdokiya Kuznetsova, Nadezhda Bakalenko, Liana Gaifullina, Mikhail Atyukov, Konstantin Dergilev, Irina Beloglazova, Anna Malashicheva

    Mesothelial cells (MCs) are highly relevant for studying the pathogenesis of serosal diseases, fibrosis, inflammation, and tumor progression. However, the isolation and maintenance of an epithelial-like phenotype of MCs in vitro remain methodologically challenging due to their tendency to undergo mesothelial-to-mesenchymal transition (MMT). In this work, we propose a combined protocol utilizing collagen IV coating, conditioned medium, and short-term ROCK inhibitor treatment, which improves cell survival. This approach enables the establishment of primary human cultures suitable for investigating mesothelial cell functional activity and for assessing the efficacy of potential therapeutic strategies.

  • Early complications after surgical treatment of spontaneous pneumothorax: risk factors analysis

    by G.M. Agafonov, A.S. Petrov, O.V. Novikova, M.A. Atyukov, P.K. Yablonsky

    Objective. To study the risk factors of complications after wedge resection with subsequent pleurectomy. Material and methods. There were 454 patients diagnosed with spontaneous pneumothorax between 2018 and 2023. Surgical intervention was performed in 331 (72.9%) patients according to commonly accepted indications for prevention of recurrence. Risk factors were studied using regression analysis and directed acyclic graph (DAG) method to build predictive models. Results. The complication rate was 11.5% (n=38). The most common complications were intrapleural bleeding and prolonged air leak (3.9% and 3.6%, respectively). One-third of cases were classified as major complications according to the Clavien-Dindo classification in thoracic surgery and required pleural cavity drainage or debridement. Significant risk factors of postoperative complications were secondary pneumothorax (HR 4.009; 95% 1.147—14.013; p=0.030) and severe pleural adhesions (HR 4.258; 95% 1.134—15.991; p=0.032). Conclusion. Secondary pneumothorax and severe pleural adhesions are independent risk factors of postoperative complications.

  • Cervicothoracotomy for right upper sleeve lobectomy with carinal resection in the treatment of central lung cancer

    by M.A. Atyukov, O.A. Zhemchugova-Zelenova, A.S. Petrov, I.YU. Zemtsova

    We demonstrated successful treatment of patients with complicated central lung cancer, who underwent right upper sleeve lobectomy with carinal resection. We have used the following options for carinal reconstruction: anastomosis of trachea with the left main bronchus and anastomosis of intermediate bronchus with the left main bronchus (clinical case No. 1) or with trachea (clinical case No. 2). Cervicothoracotomy provided correct N-staging and mobilization of trachea with left main bronchus. This approach provided compliance with oncological principles of surgical treatment of lung cancer and significantly reduced tension of anastomosis. These aspects are important for satisfactory immediate functional and oncological results after right upper sleeve lobectomy with carinal resection.

  • Open Access

    Features and outcomes of bilateral anatomical lung resections in patients with lung cancer

    by M. A. Atyukov, I. Yu. Zemtsova, A. S. Petrov, O. A. Zhemchugova-Zelenova, P. K. Yablonskiy, И. Ю. Земцова

    The aim of this study was to evaluate the feasibility and safety of sequential bilateral anatomical lung resections performed via video-assisted thoracic surgery (VATS) or thoracotomy approaches in lung cancer patients, as well as to identify factors affecting the postoperative period. Material and Methods. Of 534 NSCLC patients undergoing anatomical lung resection in Center for Intensive Pulmonology and Thoracic Surgery from 2014 to 2022, 14 patients with consecutive bilateral anatomical lung resections were included in the retrospective study. The patients were divided into two groups depending on a surgical approach used during the first surgery: group I – 5 patients underwent thoracotomy and group II – 9 patients underwent videoassisted thoracic surgery (VATS). The groups were matched for gender, age, smoking, Charlson Comorbidity Index, lung resection, functional status and stage of the disease. Surgical treatment included anatomical lung resection and ipsilateral systematic lymph dissection. Results. There were significant differences in intraoperative blood loss between the groups. Postoperative complications after surgery on the contralateral lung were observed more often in group 1 patients than in group II patents. The overall 5-year survival rates in patients of groups 1 and 2 were 60 % and 86 %, respectively. Respiratory function indicators three months after surgery corresponded to preoperative prognosis, and their decrease did not depend on the surgical approach used. In comparison with patients who underwent standard unilateral lung resection, bilateral anatomical lung resection was not associated with increased number of “major” complications, however, an increase in the frequency of prolonged air discharge was noted (26 % vs 6 %; pConclusion. Sequential bilateral anatomical lung resections are feasible and safe after thorough preoperative assessment of the functional reserves of the cardio-respiratory system. Mini-invasive technologies make it possible to reduce the frequency of complications in the early postoperative period. The use of the VATS approach makes it possible to safely perform anatomical resection of the contralateral lung.